| abstract |
The present invention provides novel pyrazolopyridine compounds, compositions and methods of treatment or prevention of IRE1α-associated diseases or disorders. In some embodiments, the disease or disorder is selected from the group consisting of a neurodegenerative disease, a demyelinating disease, cancer, an ophthalmic disease, a fibrotic disease, and diabetes. |